Sign In
Get Clay Free →

Suggestions

    Bruce Montgomery

    Chief Executive Officer with extensive experience in the pharmaceutical industry

    Bruce Montgomery is an experienced physician scientist and entrepreneur currently serving as the Chief Executive Officer of WBX Pharma in Seattle, Washington.1 He assumed this role in September 2023.1

    Career Highlights

    Dr. Montgomery has an extensive background in the pharmaceutical and biotechnology industries, spanning over 30 years. His career includes leadership positions at several prominent companies:

    • CEO of Avalyn Pharma (March 2017 - September 2023): Focused on developing treatments for idiopathic pulmonary fibrosis and other lung diseases.1
    • CEO of Cardeas Pharma (April 2011 - December 2016).1
    • Senior Vice President at Gilead Sciences (August 2006 - April 2011).13
    • CEO of Corus Pharma (2001 - 2006): Founded the company, which was later acquired by Gilead Sciences.13
    • Executive Vice President of R&D at Pathogenesis (1993 - 2000).1
    • Associate Director of Clinical Research at Genentech (1989 - 1993).1

    Achievements and Expertise

    Dr. Montgomery is known for his contributions to pulmonary and critical care medicine:

    • Led development teams for new therapies for cystic fibrosis patients, including Cayston, TOBI, and Pulmozyme.4
    • Co-invented aerosolized pentamidine, a prophylaxis for PCP in AIDS patients.4
    • Holds 28 US patents as an inventor.4
    • Successfully led six new drugs through FDA approval.3

    Education and Qualifications

    • Doctor of Medicine (MD) from the University of Washington (1971 - 1979).1
    • Bachelor of Science in Chemistry from the University of Washington.13
    • Board-certified internist and pulmonologist.34

    Dr. Montgomery has been recognized as one of the three most influential leaders in Seattle's biotech industry by the Seattle Post Intelligencer.2 His expertise in drug development, operations, and financing has made him a valuable asset in the life sciences sector.

    Related Questions

    What are Bruce Montgomery's key achievements at WBX Pharma?
    How did Bruce Montgomery's experience at Gilead Sciences influence his leadership style?
    What new drugs has Bruce Montgomery led through FDA approval?
    What are the main projects Bruce Montgomery is currently working on at WBX Pharma?
    How did Bruce Montgomery's role at Avalyn Pharma shape his career?
    Bruce Montgomery
    Bruce Montgomery, photo 1
    Bruce Montgomery, photo 2
    Add to my network

    Experience

    Chief Executive Officer at WBX Pharma (September 2023 - Present)
    - Chief Executive Officer at Avalyn Pharma (March 2017 - September 2023) - Chief Executive Officer at Cardeas Pharma (April 2011 - December 2016) - SVP at Gilead Sciences (August 2006 - April 2011) - Chief Executive Officer at Corus Pharma (2001 - 2006) - EVP R and D at Pathogenesis (1993 - 2000) - Associate Director Clinical Research at Genentech (1989 - 1993)

    Education

    Doctor of Medicine (MD) and BS in Chemistry from University of Washington (1971 - 1979)

    Location

    Seattle, Washington, United States